These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7463006)

  • 21. Separation and sugar component analysis of the oligosaccharides in the surface glycoproteins of Newcastle disease virus.
    Diabaté S; Geyer R; Stirm S
    Arch Virol; 1983; 76(4):321-34. PubMed ID: 6625884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of pathotype-specific structural features and cleavage activation of Newcastle disease virus membrane glycoproteins using antipeptide antibodies.
    Hodder AN; Selleck PW; White JR; Gorman JJ
    J Gen Virol; 1993 Jun; 74 ( Pt 6)():1081-91. PubMed ID: 8509761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maturation of the envelope glycoproteins of Newcastle disease virus on cellular membranes.
    Schwalbe JC; Hightower LE
    J Virol; 1982 Mar; 41(3):947-57. PubMed ID: 6284983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutational changes of the protease susceptibility of glycoprotein F of Newcastle disease virus: effects on pathogenicity.
    Garten W; Berk W; Nagai Y; Rott R; Klenk HD
    J Gen Virol; 1980 Sep; 50(1):135-47. PubMed ID: 7441209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strain-specific degradation of a viral glycoprotein in Newcastle disease virus-infected cells.
    Sklyanskaya EI; Kaverin NV; Gribkova NV; Tsvetkova IV; Lipkind MA
    Arch Virol; 1975; 47(2):147-55. PubMed ID: 1168041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Agglutination-separation reactions of red blood cells sensitized with Newcastle disease virus: quantities, agglutination characteristics, and serology of altered virus and HN spikes released following neuraminidase reactivation.
    Graves IL
    Vet Res; 2001; 32(5):475-89. PubMed ID: 11592617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of the isolation procedure on the structure, neuraminidase and heamagglutinating activities of Sendai virus envelope glycoproteins.
    Popa LM; Repanovici R; Samuel I
    Acta Virol; 1978 Nov; 22(6):433-42. PubMed ID: 35940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fatty acid modification of Newcastle disease virus glycoproteins.
    Chatis PA; Morrison TG
    J Virol; 1982 Jul; 43(1):342-7. PubMed ID: 7109029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nucleotide sequence of the haemagglutinin-neuraminidase (HN) gene of a Malaysian heat resistant viscerotropic-velogenic Newcastle disease virus (NDV) strain AF2240.
    Tan WS; Lau CH; Ng BK; Ibrahim AL; Yusoff K
    DNA Seq; 1995; 6(1):47-50. PubMed ID: 8746461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new structural protein for Newcastle disease virus.
    Chambers P; Samson AC
    J Gen Virol; 1980 Sep; 50(1):155-66. PubMed ID: 7441211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Restoration of the biological activity of hemagglutinin--neuraminidase in NDV with phospholipids].
    Vasileva L; Dumanova L
    Vet Med Nauki; 1984; 21(9):33-7. PubMed ID: 6528478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antipeptide antibodies for analysis of pathotype-specific variations in cleavage activation of the membrane glycoprotein precursors of Newcastle disease virus isolates in cultured cells.
    Gorman JJ; Hodder AN; Selleck PW; Hansson E
    J Virol Methods; 1992 Apr; 37(1):55-70. PubMed ID: 1572931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Correlation between structure and pathogenicity of myxoviruses (author's transl)].
    Rott R; Klenk HD; Scholtissek C
    Arzneimittelforschung; 1977 Jan; 27(1B):208-12. PubMed ID: 576826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The spread of a pathogenic and an apathogenic strain of Newcastle disease virus in the chick embryo as depending on the protease sensitivity of the virus glycoproteins.
    Nagai Y; Shimokata K; Yoshida T; Hamaguchi M; Iinuma M; Maeno K; Matsumoto T; Klenk HD; Rott R
    J Gen Virol; 1979 Nov; 45(2):263-72. PubMed ID: 396357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parainfluenza virus surface projections: glycoproteins with haemagglutinin and neuraminidase activities.
    Chen C; Compans RW; Choppin PW
    J Gen Virol; 1971 Apr; 11(1):53-8. PubMed ID: 4325089
    [No Abstract]   [Full Text] [Related]  

  • 36. The structural proteins of Newcastle disease virus.
    Haslam EA; Cheyne IM; White DO
    Virology; 1969 Sep; 39(1):118-29. PubMed ID: 5807968
    [No Abstract]   [Full Text] [Related]  

  • 37. Viral pathogenesis: mechanism of acute and persistent infections with paramyxoviruses.
    Nagai Y; Yoshida T
    Nagoya J Med Sci; 1984 Mar; 46(1-4):1-17. PubMed ID: 6330558
    [No Abstract]   [Full Text] [Related]  

  • 38. Isolation and purification of the envelope proteins of Newcastle disease virus.
    Scheid A; Choppin PW
    J Virol; 1973 Feb; 11(2):263-71. PubMed ID: 4734650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamics of functional maturation and inactivation of HN glycoprotein in NDV-infected chick embryo fibroblasts.
    Lipkind M; Urbakh V
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Jan; 267(3):432-49. PubMed ID: 3376620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stability in Newcastle disease virus-infected cells of HN protein which lost its functional activity under conditions of protein synthesis inhibition by cycloheximide.
    Vovk TS; Zaides VM; Kaverin NV
    Acta Virol; 1979 Nov; 23(6):449-54. PubMed ID: 44662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.